找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Universalising Healthcare in India; From Care to Coverag Imrana Qadeer,K. B. Saxena,P. M. Arathi Book 2021 The Editor(s) (if applicable) an

[復制鏈接]
樓主: morphology
11#
發(fā)表于 2025-3-23 12:18:16 | 只看該作者
12#
發(fā)表于 2025-3-23 16:09:45 | 只看該作者
13#
發(fā)表于 2025-3-23 19:46:27 | 只看該作者
Interrogating the Proposed Universal Healthcare in India Through a ‘Quality’ LensRising health inequalities, catastrophic healthcare costs pushing people below the poverty line, along with glaring gaps between economic growth rates and health status of people have raised many questions about the post-liberalisation health sector reforms in India.
14#
發(fā)表于 2025-3-24 02:12:25 | 只看該作者
15#
發(fā)表于 2025-3-24 03:23:29 | 只看該作者
Role of Public Private Partnerships in Ensuring Universal Healthcare for IndiaIn the early 1990s Health Sector Reforms (HSR) undertaken as part of structural adjustment programmes proposed a range of changes in governance, provisioning, financing and resource generation.
16#
發(fā)表于 2025-3-24 06:31:07 | 只看該作者
17#
發(fā)表于 2025-3-24 12:00:51 | 只看該作者
Universal Healthcare and Universalising Health Insurance: Examining the Binary Through the RSBY/MSBYThe Rashtriya Swasthya Bima Yojana (RSBY) is a state-funded health insurance scheme in India, targeted at families living Below Poverty Line (BPL).
18#
發(fā)表于 2025-3-24 15:14:42 | 只看該作者
Aarogyasri Scheme in Andhra Pradesh, India: Some Critical ReflectionsUniversal Health Coverage (UHC) is currently being debated all over the world and the ruling Bharatiya Janata Party (BJP) government in India has now brought in the idea of health assurance.
19#
發(fā)表于 2025-3-24 20:36:06 | 只看該作者
20#
發(fā)表于 2025-3-25 01:04:48 | 只看該作者
Drugs and Vaccines in Healthcare: Problems and PossibilitiesThe problems with regard to the use of allopathic drugs in India range from quality and regulation to irrational use because of the nexus between pharmaceutical companies and the largely commercial healthcare establishments. Fake or sub-standard allopathic drugs may represent as much as 25% of our drugs.
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2026-1-20 08:53
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
万盛区| 南投县| 栾川县| 新巴尔虎左旗| 泗阳县| 新巴尔虎左旗| 岑溪市| 太和县| 岱山县| 临颍县| 吉水县| 江安县| 邳州市| 新晃| 丹凤县| 山西省| 澄迈县| 阿鲁科尔沁旗| 平果县| 阿荣旗| 东源县| 营口市| 光山县| 准格尔旗| 怀远县| 全州县| 寻甸| 宜城市| 尼玛县| 翁牛特旗| 竹溪县| 关岭| 乌拉特中旗| 洞口县| 惠水县| 黄冈市| 绥宁县| 怀宁县| 二连浩特市| 连平县| 池州市|